Innovation in bcma car-t therapy: building beyond the model t

HIGHLIGHTS

• who: Rahul Banerjee from the Icahn School of Medicine at Mount Sinai, United States Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, United have published the paper: Innovation in BCMA CAR-T therapy: Building beyond the Model T, in the Journal: (JOURNAL)
• what: Strategies to improve the durability of responses to BCMA CAR-T therapy thus constitute a key area of innovation which can be classified into two groups : ex vivo approaches focused on CAR manufacturing, and_(2) in_vivo approaches focused on the modulation of the immune system.
• future . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.